返回
Cabazitaxel
DOI:10.1038/nrd3254.png)
摘要
En
Keyword:
RESISTANT PROSTATE-CANCER
EVERY 3 WEEKS
ANTITUMOR-ACTIVITY
PHASE-II
MULTICENTER
DOCETAXEL
TAXANE
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
101.8
论文数:
5.1K
被引数:
5.3W
机构
引用论文
Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer
CANCER RESEARCH
IF16.6
A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients
ANNALS OF ONCOLOGY
IF65.4
Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
CANCER RESEARCH
IF16.6

